These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25953961)

  • 1. Retention, transfer out and loss to follow-up two years after delivery in a cohort of HIV+ pregnant women in Malawi.
    Giuliano M; Liotta G; Andreotti M; Mancinelli S; Buonomo E; Scarcella P; Amici R; Jere H; Sagno JB; Di Gregorio M; Marazzi MC; Vella S; Palombi L
    Int J STD AIDS; 2016 May; 27(6):462-8. PubMed ID: 25953961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
    Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
    Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coverage of highly active antiretroviral therapy among postpartum women in Malawi.
    Kumwenda J; Matchere F; Mataya R; Chen S; Mipando L; Li Q; Kumwenda NI; Taha TE
    Int J STD AIDS; 2011 Jul; 22(7):368-72. PubMed ID: 21729953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
    Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
    Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery.
    Giuliano M; Andreotti M; Liotta G; Jere H; Sagno JB; Maulidi M; Mancinelli S; Buonomo E; Scarcella P; Pirillo MF; Amici R; Ceffa S; Vella S; Palombi L; Marazzi MC
    PLoS One; 2013; 8(7):e68950. PubMed ID: 23894379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
    Galluzzo C; Liotta G; Andreotti M; Luhanga R; Jere H; Mancinelli S; Maulidi M; Sagno JB; Pirillo M; Erba F; Amici R; Ceffa S; Marazzi MC; Vella S; Palombi L; Giuliano M
    J Med Virol; 2012 Oct; 84(10):1553-7. PubMed ID: 22930502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
    Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
    Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
    Onoya D; Sineke T; Brennan AT; Long L; Fox MP
    AIDS; 2017 Jul; 31(11):1593-1602. PubMed ID: 28463877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.
    de Lourdes Teixeira M; Nafea S; Yeganeh N; Santos E; Gouvea MI; Joao E; Ceci L; Bressan C; Cruz ML; Sidi LC; Nielsen-Saines K
    Int J STD AIDS; 2015 Nov; 26(13):922-8. PubMed ID: 25504831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique.
    Liotta G; Mancinelli S; Nielsen-Saines K; Gennaro E; Scarcella P; Magid NA; Germano P; Jere H; Guidotti G; Buonomo E; Ciccacci F; Palombi L; Marazzi MC
    PLoS One; 2013; 8(8):e71653. PubMed ID: 23990966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viro-immunological response and emergence of resistance in HIV-infected women receiving combination antiretroviral regimens for the prevention of mother-to-child transmission in Malawi.
    Palombi L; Galluzzo CM; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Luhanga R; Mancinelli S; Ceffa S; Amici R; Marazzi MC; Vella S; Giuliano M
    J Antimicrob Chemother; 2014 Mar; 69(3):749-52. PubMed ID: 24135952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort.
    Altan AM; Taafo F; Fopa F; Buonomo E; Marazzi MC; Nielsen-Saines K; Orlando S; Scarcella P; Ciccacci F; Mancinelli S; Lio MM; Palombi L
    Pan Afr Med J; 2016; 23():72. PubMed ID: 27217896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated with Postpartum Loss to Follow-Up and Detectable Viremia After Delivery Among Pregnant Women Living with HIV.
    Adhikari EH; Yule CS; Roberts SW; Rogers VL; Sheffield JS; Kelly MA; McIntire DD; Barnes A
    AIDS Patient Care STDS; 2019 Jan; 33(1):14-20. PubMed ID: 30601060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.
    Phillips T; Thebus E; Bekker LG; Mcintyre J; Abrams EJ; Myer L
    J Int AIDS Soc; 2014; 17(1):19242. PubMed ID: 25301494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.